My neuro put me on the list today for participating in this clinical trial of GZ/SAR402671 also known as ibiglustat. I have a GBA mutation and have been waiting for this moment. But she said something interesting: as someone with mild disease progression--at this point--I should consider carefully whether I want to risk the side effects. So now I am reading all I can of what those potential side effects might be. Jumping the gun, as usual. But she said, recruitment should officially begin soon, possibly this summer.